BucalossiP., and VeronesiU.: Pituitary ablation with I90 implant in advanced thyroid cancer.Cancer, 20: 724–726, 1967.
2.
CascinelliN., DartoliC., e TurriM.: Metastasi a distanza nei carcinomi della tiroide.Tumori, 53: 141–142, 1967.
3.
CordierC., DargentM., et GarnierM.: Cancer du corps thyroïde.Recueils du 68ème Congrès Français de Chirurgie. p. 205–400. Association Française de Chirurgie, Paris, 1966.
4.
DargentM., ColonJ., and LahnecheB.: Metastases from thyroid cancer.Tumori, 55: 67–77, 1969.
5.
DargentM., ColonJ., and LahnecheB.: Prognosis of metastases from thyroid cancer.Tumori, 55: 241–254, 1969.
6.
DargentM., ColonJ., GuillaudM., et YagmaiM.: Indications et technique de la chirurgie ganglionnaire du cancer thyroïdien.Rev. Lyon. Med., 15: 59–64, 1966.
7.
DorffelE., und MopertS.: Die radiojodbehandlung der struma maligna.Radiobiol. Radiother., 7: 311–313, 1966.
8.
FinsterbuchW., und OserW.: Struma Hepatis Permagna.Langenbecks Arch., 314: 137–148, 1966.
9.
Gerard-MarchantR.: Les ectopies thyroïdiennes.J. Chir., 93: 71–81, 1967.
10.
GikasP. W., LabowS., DigiulioW., and FingerJ. E.: Occult metastasis from occult papillary carcinoma of the thyroid.Cancer, 20: 2100–2104, 1967.
11.
HalesI. B., ReeveT. S., and StanleyP. G.: Functioning follicular metastatic carcinoma of the thyroid gland.Med. J. Austr., 51: 708–710, 1964.
12.
HamburgerJ. I., and DesaiP.: Mannitol augmentation of 131I uptake in the treatment of thyroid cancer.Metabolism, 15: 1055–1057, 1966.
13.
IbanezM. K., RusselW. D., Albores-SaavedraJ., LamperticoP., WhiteE. C., and ClarkR. L.: Thyroid carcinoma. Biologic behavior and mortality. Post mortem findings in 42 cases, including 27 in which the disease was fatal.Cancer, 19: 1039–1052, 1966.
14.
MolnarC. D., ColbyMcJr., and WoolnerL. B.: Clinics of endocrine and metabolic diseases. Demonstration of thyroid stimulating hormone dependance in a case of metastatic carcinoma of thyroid origin.Proc. Mayo Clinic, 38: 280–288, 1963.
15.
PochinE. E.: Prospects from the treatment of thyroid carcinoma by radio Iodine.Clin. Radiol., 18: 113–125, 1967.
16.
RedonM., et DupasM.: Le problème des cancers plurifocaux du corps thyroïde.Ann. Chir., 17: 1511–1522, 1963.
17.
SachatsievA., RaitschevR., und OreschkowW.: Uber die indikationen zur anwendung von radiojod bei der Schilddrüsen Krebs-behandlung.Strahlentherapie, 130: 219–225, 1966.
18.
SavoieJ. C., et GarnierM.: A propos d'une série de 145 cas de cancers thyroïdiens et du traitement par thyroïdectomie totale completée par le Radio Iode.Presse med., 75: 2095–2100, 1967.
19.
ShelineC. E., GalanteM., and LindsayS.: Radiationtherapy in the control of persistant thyroid cancer.Amer. J. Roentgenol., 97: 923–930, 1966.
20.
SilinkK. I., NemekJ., and KubalJ.: Radiation sickness after therapeutic administration of 806 mcd of 131I for thyroid cancer.Nucl. Med., 6: 170, 1967.
21.
SmedalM. I., SalzmannF. A., and MeissmerW. A.: The value of 2 mev. Roentgen Ray therapy in differentiated thyroid carcinoma.Amer. J. Roentgenol., 99: 352–364, 1967.
22.
SmetsW., et DorP.: Tendance actuelles dans le traitement du cancer thyroïdien.Lille chir., 26: 6, 1965.
23.
TubianaM., et MabilleJ. P.: L'iode radio-actif et le cancer de la thyroïde. Indications thérapeutiques.J. Radiol. Electrol., 44: 381–388, 1963.
24.
VoutilainenA., and VirtanenU. K.: The importance of PB 131 in metastasis of thyroid cancer.Ann. Med. Intern. Fenn., 55: 121–124, 1966.
25.
WadeJ. S. H.: Secondary deposits in occipital bone 28 years after removal of thyroid carcinoma.Proc. roy. Soc. Med., 58: 508–510, 1965.
26.
WinshipTh.: Management of patients with cancer of the thyroid.Cancer, 20: 1815–1818, 1967.
27.
ZhitnyurR. I., and TsyvkinM. V.: Metastases of thyroid carcinoma in bones of the skull and vertebral column.Vestn. Khir., 97: 22–25, 1966.
28.
ZuppingerA.: Die struma maligna.Praxis, 55: 550–556, 1966.
